Dongsung Chemical Co., Ltd.

KRX:102260.KS

4300 (KRW) • At close July 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

20242023202220212020201920182017201620152014201320122011201020092008
Revenue 1,066,318.1131,117,998.8541,140,123.62925,978.52882,050.841849,786.144813,073.125827,336.387852,912.858871,224.899905,441.155823,409.697654,021.296582,112.775505,111.439529,645.397288,366.171
Cost of Revenue 869,512.592944,251.796994,564.1788,827.449718,908.053701,871.558718,053.309735,222.486697,126.952718,164.252772,929.478706,293.035546,835.126503,706.822433,499.398436,055.247254,711.395
Gross Profit 196,805.521173,747.058145,559.52137,151.071163,142.788147,914.58695,019.81692,113.901155,785.906153,060.647132,511.677117,116.663107,186.1778,405.95371,612.04193,590.1533,654.776
Gross Profit Ratio 0.1850.1550.1280.1480.1850.1740.1170.1110.1830.1760.1460.1420.1640.1350.1420.1770.117
Reseach & Development Expenses 4,031.313,529.8512,284.7491,793.2152,041.0572,564.8281,743.5251,452.5721,697.9971,242.781,216.166426.702517.381,578.956140.997439.608253.76
General & Administrative Expenses 10,743.7148,780.1298,215.4557,817.4087,353.7578,450.7987,200.8046,975.7129,845.18810,580.558,298.5498,426.7467,507.4215,654.8047,095.2415,153.1894,432.305
Selling & Marketing Expenses 25,565.03929,741.87432,702.4129,790.06625,502.49624,925.43122,990.23823,446.77526,547.65222,500.74526,284.44524,194.87417,574.43513,203.84411,767.63513,191.1148,119.681
SG&A 36,308.75338,522.00340,917.86537,607.47432,856.25233,376.22930,191.04230,422.48736,392.8433,081.29434,582.99432,621.62125,081.85618,858.64918,862.87528,344.30312,551.986
Other Expenses 65,435.54358,066.27946,895.18748,119.63267,071.83259,743.6111,314.9191,478.856509.6344,999.078-5,001.422928.7962,689.598-5,501.3733,189.3621,337.981250.773
Operating Expenses 105,775.60589,553.87890,097.887,520.32101,969.14195,684.66787,042.18688,459.39190,746.38286,372.63682,481.89473,179.97263,062.09753,145.71846,873.09956,717.10727,906.413
Operating Income 91,029.91681,599.86655,370.34345,320.05561,173.64751,825.7327,777.6293,654.5165,039.52466,688.01150,029.78343,936.69144,124.07324,634.03424,738.94336,873.0425,748.363
Operating Income Ratio 0.0850.0730.0490.0490.0690.0610.010.0040.0760.0770.0550.0530.0670.0420.0490.070.02
Total Other Income Expenses Net -2,020.947-13,114.012-5,796.9868,315.686-9,726.707-16,558.996-11,415.906-8,909.0391.56-9,397.566-18,655.609-15,254.014-6,451.629-15,362.144-6,985.344-49,066.702-1,581.573
Income Before Tax 89,008.96968,485.85455,772.69853,635.7448,500.59235,266.7372,930.1271,362.90670,450.3157,290.44531,374.17328,682.67837,672.4459,271.8917,753.599-12,193.664,166.79
Income Before Tax Ratio 0.0830.0610.0490.0580.0550.0420.0040.0020.0830.0660.0350.0350.0580.0160.035-0.0230.014
Income Tax Expense 27,811.0949,770.6018,939.70412,195.9511,318.95410,246.2187,754.337,294.92617,471.02413,733.6492,268.83510,635.0737,464.5527,168.9478,452.1413,446.1072,826.771
Net Income 44,950.87133,453.89946,832.99441,439.7937,181.63725,020.518-3,219.199,812.50837,468.98620,287.7547,282.277598.91814,824.065-1,778.2511,873.133902.619-8,515.858
Net Income Ratio 0.0420.030.0410.0450.0420.029-0.0040.0120.0440.0230.0080.0010.023-0.0030.0040.002-0.03
EPS 924687954.02858.8845.17568.74-73.1822384650820322554-75.1483.244.6-540.2
EPS Diluted 916681.71945.62846.84839.39560.69-7322083049719918401-59.9183.244.6-540.2
EBITDA 119,330.901104,968.24588,828.6189,616.52191,074.23972,289.60635,108.15730,222.84589,521.8686,049.48164,874.80460,625.9765,295.90539,131.33648,112.02722,784.74611,439.914
EBITDA Ratio 0.1120.0940.0780.0970.1030.0850.0430.0370.1050.0990.0720.0740.10.0670.0950.0430.04